180 Life Sciences Corp.

NasdaqCM:ATNF Stock Report

Market Cap: US$3.4m

180 Life Sciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Lloyd Jordan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure2.9yrs

Recent management updates

Recent updates

180 Life Sciences to raise $6.5M in direct stock offering

Jul 18

180 Life Sciences: Looking At Inflammation With Cannabis (Podcast)

Sep 08

What Type Of Shareholders Make Up 180 Life Sciences Corp.'s (NASDAQ:ATNF) Share Registry?

Feb 17
What Type Of Shareholders Make Up 180 Life Sciences Corp.'s (NASDAQ:ATNF) Share Registry?

SPAC biotech 180 Life Sciences to ring Nasdaq opening bell today

Nov 27

CEO

Lloyd Jordan (55 yo)

less than a year

Tenure

Mr. Lloyd Blair Jordan MBA, LL B, is the Managing Partner of Restructur Advisors. He serves as an Independent Director at Minas Metals Ltd.(formerly known as Lode Metals Corp.) since March 29, 2023. Mr. J...

Board Members

NamePositionTenureCompensationOwnership
Lawrence Steinman
Co-Founder & Director5.8yrsUS$253.52k0.13%
$ 4.4k
Lloyd Jordan
Interim CEOless than a yearno datano data
Jagdeep Nanchahal
Co-Founder & Chairman of Clinical Advisory Boardno datano datano data
Stephen Shoemaker
Directorless than a yearno datano data
Kevin Tracey
Member of Scientific Advisory Board2.9yrsno datano data
Chas Bountra
Member of Scientific Advisory Board2.9yrsno datano data
Ryan Smith
Independent Directorless than a yearno datano data
Irene Tracey
Member of Scientific Advisory Board2.9yrsno datano data
Sallie Lamb
Member of Scientific Advisory Board2.9yrsno datano data
Jay Goodman
Independent Directorless than a yearno datano data

2.9yrs

Average Tenure

55yo

Average Age

Experienced Board: ATNF's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 20:32
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

180 Life Sciences Corp. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Jason McCarthyMaxim Group
Nazibur RahmanMaxim Group